Assesment of SARS-CoV-2 infection-in dentists and supporting staff at a university dental hospital in Argentina.
COVID-19
COVID-19 testing
Dentistry
Epidemiology
SARs-Cov2 infection
Journal
Journal of oral biology and craniofacial research
ISSN: 2212-4268
Titre abrégé: J Oral Biol Craniofac Res
Pays: Netherlands
ID NLM: 101619156
Informations de publication
Date de publication:
Historique:
received:
05
12
2020
revised:
29
12
2020
accepted:
02
01
2021
entrez:
1
2
2021
pubmed:
2
2
2021
medline:
2
2
2021
Statut:
ppublish
Résumé
Oral healthcare professionals are at increased risk of infection by SARS-CoV-2. The aim of this study was to evaluate the prevalence of COVID-19 in a population of workers who provided services during the COVID-19 pandemic at a dental care and educational institution in the Buenos Aires Metropolitan Area. This was a descriptive, cross-sectional study including 358 workers who provided essential services during the first 180 days of the COVID-19 pandemic at the Dental Hospital at Buenos Aires University School of Dentistry (FOUBA). Following epidemiological data, these workers underwent diagnostic testing for COVID-19 (1- nasal or throat swab tests; 2- blood test for enzyme-linked immunosorbent assays [ELISA]; 3- commercial rapid serology test). Three diagnostic tests were implemented. Rapid tests were performed on 290 subjects, with 255 negative results (88%; CI95: 84%-91%) and 35 positive (12%; CI95: 9%-16%); ELISA on 317 subjects, with 308 negative (97%; CI95: 95%-98%) and 9 positive (3%; CI95: 2%-5%); and PCR on 204 subjects, with 196 negative (96%; CI95: 92%-98%) and 8 positive (4%; CI95: 2%-8%). There were 358 subjects who were evaluated by ELISA or PCR, with 342 negative results (96%; CI95: 93%-97%) and 16 positives (4%; CI95: 3%-7%). For this sample of dentists, dental assistants and nonclinical personnel, the weighted prevalence of COVID-19 was 4%. Similar studies should be conducted at other dental care facilities in order to evaluate the worldwide impact of COVID-19 on the dental care community.
Identifiants
pubmed: 33520644
doi: 10.1016/j.jobcr.2021.01.006
pii: S2212-4268(21)00006-3
pmc: PMC7832657
doi:
Types de publication
Journal Article
Langues
eng
Pagination
169-173Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Dent Res. 2020 May;99(5):481-487
pubmed: 32162995
Elife. 2020 May 11;9:
pubmed: 32392129
Clin Chim Acta. 2020 Nov;510:35-46
pubmed: 32621814
J Am Dent Assoc. 2020 Nov;151(11):815-824
pubmed: 33071007
J Dent Res. 2020 Aug;99(9):1030-1038
pubmed: 32302257
JAMA Netw Open. 2020 May 1;3(5):e209666
pubmed: 32437575
Lancet Infect Dis. 2020 Nov;20(11):1273-1280
pubmed: 32622380
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):374-384
pubmed: 32704470
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Clin Infect Dis. 2020 Dec 17;71(10):2702-2707
pubmed: 32548613
JAMA Netw Open. 2020 May 1;3(5):e209673
pubmed: 32437576
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934
pubmed: 32306047
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Clin Med. 2020 Mar 31;9(4):
pubmed: 32244365
Int J Infect Dis. 2020 Nov;100:386-389
pubmed: 32949777
J Pediatr (Rio J). 2021 Jan-Feb;97(1):7-12
pubmed: 32882235
J Clin Virol. 2020 Nov;132:104645
pubmed: 32961429